hotspot -WSS

hotspot

author：explore 2025-09-10 08:44:35 - browse：6224

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Should insurance cover cosmetic surgery?

hotspot

WSS

Flu, Covid vaccination rates decline, new survey data show

Experts study whether long Covid risk adds up with each reinfection

Stroke rates rising, especially in working

Some medical students still think black patients feel less pain

European officials brace for rough respiratory virus season

Lawsuit highlights wrinkle for disputes over surprise medical bills

hotspot

hotspot

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

Study points to new risk in gene therapy death of Terry Horgan

ChatGPT in medicine: STAT answers readers' burning questions

Medical students need to learn the potent medicine of empathy

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bird flu makes raw milk dangerous to consume, mouse study finds

How to save PrEP access — and even expand it

WHO recommends second malaria vaccine

New air purifier tech could be key to improving indoor air quality

Medicare innovation center doesn’t save money, experts say

Wikipedia

U.S. death rates show how politics are affecting public health

Lawsuit highlights wrinkle for disputes over surprise medical bills

Lawsuit challenges CMS nursing home minimum staffing rule

What we owe ALS patients — and why one company fell short

The Karikó problem: Lessons for funding basic research

Clinicians often fail to acknowledge the pain caused by long Covid

leisure time

focus

hotspot

hotspot